Find a Clinical Trial

Physicians

Learn how we help support and foster independent practices.

Visit Site

Patients

Learn how we help make patient care our number one priority.

Visit Site

Find a Clinical Trial

Use the abbreviation for your state (ie. FL, TX, NV)
Search by practice name, trial titles, indicators and specific disease types.

Ovarian Cancer

Clinical Trial at: Arizona Oncology - Sedona

A Phase II Open-Label Study of NUC-1031 in Patients with Platinum-Resistant Ovarian Cancer (PRO-105)

  • Details

ClinicalTrials.gov ID: NCT03146663
Diagnosis Type: NA
USOR Number: 16220

  • Practice Details

3700 W State Route 89A
Sedona, Arizona 86336
P: (928) 204-4163

More Details View Practice Page

Head and Neck Cancer

Clinical Trial at: Arizona Oncology - Tucson

An Open-label Phase 2 Multi-cohort Trial of Nivolumab in Advanced or Metastatic Malignancies (CA209627)

  • Details

ClinicalTrials.gov ID: NCT02832167
Diagnosis Type: NA
USOR Number: 16041

  • Practice Details

1845 W Orange Grove, Bldg 2
Tucson, Arizona 85704
P: (520) 531-8967

More Details View Practice Page

Lung Cancer

Clinical Trial at: Arizona Oncology - Glendale

CA209-817: A Phase IIIb/IV Safety and Efficacy Trial of Flat Dose Nivolumab in Combination with Ipilimumab in Participants with Non-Small Cell Lung Cancer

  • Details

ClinicalTrials.gov ID: NCT02869789
Diagnosis Type: NSCLC
USOR Number: 16156

  • Practice Details

7200 W Bell Road, Building A
Glendale, Arizona 85308
P: (623) 487-4822

More Details View Practice Page

Head and Neck Cancer

Clinical Trial at: Arizona Oncology - Tucson

An Open-label Phase 2 Multi-cohort Trial of Nivolumab in Advanced or Metastatic Malignancies (CA209627)

  • Details

ClinicalTrials.gov ID: NCT02832167
Diagnosis Type: NA
USOR Number: 16041

  • Practice Details

603 N Wilmot Rd, Suite 151
Tucson, Arizona 85711
P: (520) 886-0206

More Details View Practice Page

Lung Cancer

Clinical Trial at: Arizona Oncology - Phoenix

Randomized, Open-Label, Phase 3 Trial of Nivolumab plus Ipilimumab or Nivolumab plus Platinum-Doublet Chemotherapy versus Platinum-Doublet Chemotherapy in Early Stage NSCLC (CA209-816)

  • Details

ClinicalTrials.gov ID: NCT02998528
Diagnosis Type: NSCLC
USOR Number: 16161

  • Practice Details

19646 N 27th Avenue, Suite 406
Phoenix, Arizona 85027
P: (602) 357-2400

More Details View Practice Page

Melanoma

Clinical Trial at: Arizona Oncology - Phoenix

A PHASE III, DOUBLE-BLINDED, RANDOMIZED, PLACEBO CONTROLLED STUDY OF ATEZOLIZUMAB PLUS COBIMETINIB AND VEMURAFENIB VERSUS PLACEBO PLUS COBIMETINIB AND VEMURAFENIB IN PREVIOUSLY UNTREATED BRAFV600 MUTATION-POSITIVE PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED OR METASTATIC MELANOMA (CO39262)

  • Details

ClinicalTrials.gov ID: NCT02908672
Diagnosis Type: NA
USOR Number: 17078

  • Practice Details

2222 E Highland Ave, Suite 400
Phoenix, Arizona 85016
P: (602) 277-4868

More Details View Practice Page

Breast Cancer

Clinical Trial at: Arizona Oncology - Tucson

CLEE011G2301: A phase III, multicenter, randomized, double-blind, placebo-controlled study to evaluate efficacy and safety of ribociclib with endocrine therapy as an adjuvant treatment in patients with hormone receptor-positive, HER2-negative, high risk early breast cancer

  • Details

ClinicalTrials.gov ID: NCT03078751
Diagnosis Type: NA
USOR Number: 16228

  • Practice Details

1845 W Orange Grove, Bldg 2
Tucson, Arizona 85704
P: (520) 531-8967

More Details View Practice Page

Biliary Cancer

Clinical Trial at: Arizona Oncology - Tucson

An Open-label Phase 2 Multi-cohort Trial of Nivolumab in Advanced or Metastatic Malignancies (CA209627)

  • Details

ClinicalTrials.gov ID: NCT02832167
Diagnosis Type: NA
USOR Number: 16041

  • Practice Details

2070 W Rudasill Rd, Suite 130
Tucson, Arizona 85704
P: (520) 797-4468

More Details View Practice Page

Breast Cancer

Clinical Trial at: Arizona Oncology - Sedona

(I3Y-MC-JPCF)A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined with Standard Adjuvant Endocrine Therapy versus Standard Adjuvant Endocrine Therapy Alone in Patients with High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer

  • Details

ClinicalTrials.gov ID: NCT03155997
Diagnosis Type: NA
USOR Number: 17082

  • Practice Details

3700 W State Route 89A
Sedona, Arizona 86336
P: (928) 204-4163

More Details View Practice Page

Lymphomas

Clinical Trial at: Arizona Oncology - Phoenix

An Open-Label, Multicenter, Phase 1/2 Study of Tazemetostat (EZH2 Histone Methyl Transferase [HMT] Inhibitor) as a Single Agent in Subjects With Advanced Solid Tumors or With B Cell Lymphomas and Tazemetostat in Combination With Prednisolone in Subjects With Diffuse Large B Cell Lymphoma - E7438-G000-101

  • Details

ClinicalTrials.gov ID: NCT01897571
Diagnosis Type: Non-Hodgkins
USOR Number: 16248

  • Practice Details

19646 N 27th Avenue, Suite 406
Phoenix, Arizona 85027
P: (602) 357-2400

More Details View Practice Page

Myelomas

Clinical Trial at: Arizona Oncology - Phoenix

Multiple Myeloma Patient Registry

  • Details

ClinicalTrials.gov ID: NCT03180853
Diagnosis Type: NA
USOR Number: 17028

  • Practice Details

19646 N 27th Avenue, Suite 406
Phoenix, Arizona 85027
P: (602) 357-2400

More Details View Practice Page

Ovarian Cancer

Clinical Trial at: Arizona Oncology - Phoenix

PR-30-5017-C: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Niraparib Maintenance Treatment in Patients with Advanced Ovarian Cancer Following Response On Front-Line Platinum-Based Chemotherapy (PRIMA)

  • Details

ClinicalTrials.gov ID: NCT02655016
Diagnosis Type: NA
USOR Number: 16211

  • Practice Details

2222 E Highland Ave, Suite 400
Phoenix, Arizona 85016
P: (602) 277-4868

More Details View Practice Page

Renal Cancer

Clinical Trial at: Arizona Oncology - Phoenix

A Phase III, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (KEYNOTE-564)

  • Details

ClinicalTrials.gov ID: NCT03142334
Diagnosis Type: NA
USOR Number: 16251

  • Practice Details

19646 N 27th Avenue, Suite 406
Phoenix, Arizona 85027
P: (602) 357-2400

More Details View Practice Page

Peritoneal Cancer

Clinical Trial at: Arizona Oncology - Tucson

A PHASE III, MULTICENTER, RANDOMIZED, STUDY OF ATEZOLIZUMAB VERSUS PLACEBO ADMINISTERED IN COMBINATION WITH PACLITAXEL, CARBOPLATIN, AND BEVACIZUMAB TO PATIENTS WITH NEWLY-DIAGNOSED STAGE III OR STAGE IV OVARIAN, FALLOPIAN TUBE, OR PRIMARY PERITONEAL CANCER - YO39523

  • Details

ClinicalTrials.gov ID: NCT03038100
Diagnosis Type: NA
USOR Number: 16233

  • Practice Details

1845 W Orange Grove, Bldg 2
Tucson, Arizona 85704
P: (520) 531-8967

More Details View Practice Page

Solid Tumors

Clinical Trial at: Arizona Oncology - Tucson

An Open-label Phase 2 Multi-cohort Trial of Nivolumab in Advanced or Metastatic Malignancies (CA209627)

  • Details

ClinicalTrials.gov ID: NCT02832167
Diagnosis Type: NA
USOR Number: 16041

  • Practice Details

2070 W Rudasill Rd, Suite 130
Tucson, Arizona 85704
P: (520) 797-4468

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Arizona Oncology - Phoenix

TRITON3: A Multicenter, Randomized, Open-label Phase 3 Study of Rucaparib versus Physician's Choice of Therapy for Patients with Metastatic Castration-resistant Prostate Cancer Associated with Homologous Recombination Deficiency (CO-338-063)

  • Details

ClinicalTrials.gov ID: NCT02975934
Diagnosis Type: NA
USOR Number: 16238

  • Practice Details

19646 N 27th Avenue, Suite 406
Phoenix, Arizona 85027
P: (602) 357-2400

More Details View Practice Page

Renal Cancer

Clinical Trial at: Arizona Oncology - Glendale

A Phase III, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (KEYNOTE-564)

  • Details

ClinicalTrials.gov ID: NCT03142334
Diagnosis Type: NA
USOR Number: 16251

  • Practice Details

7200 W Bell Road, Building A
Glendale, Arizona 85308
P: (623) 487-4822

More Details View Practice Page

Ovarian Cancer

Clinical Trial at: Arizona Oncology - Scottsdale

A RANDOMIZED, OPEN-LABEL, MULTICENTER, PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF AVELUMAB (MSB0010718C) IN COMBINATION WITH AND/OR FOLLOWING CHEMOTHERAPY IN PATIENTS WITH PREVIOUSLY UNTREATED EPITHELIAL OVARIAN CANCER (B9991010)

  • Details

ClinicalTrials.gov ID: NCT02718417
Diagnosis Type: NA
USOR Number: 16080

  • Practice Details

10460 N 92nd St, Suite 402
Scottsdale, Arizona 85258
P: (480) 860-2540

More Details View Practice Page

Mesothelioma

Clinical Trial at: Arizona Oncology - Tucson

An Open-label Phase 2 Multi-cohort Trial of Nivolumab in Advanced or Metastatic Malignancies (CA209627)

  • Details

ClinicalTrials.gov ID: NCT02832167
Diagnosis Type: NA
USOR Number: 16041

  • Practice Details

1845 W Orange Grove, Bldg 2
Tucson, Arizona 85704
P: (520) 531-8967

More Details View Practice Page

Mesothelioma

Clinical Trial at: Arizona Oncology - Tucson

An Open-label Phase 2 Multi-cohort Trial of Nivolumab in Advanced or Metastatic Malignancies (CA209627)

  • Details

ClinicalTrials.gov ID: NCT02832167
Diagnosis Type: NA
USOR Number: 16041

  • Practice Details

603 N Wilmot Rd, Suite 151
Tucson, Arizona 85711
P: (520) 886-0206

More Details View Practice Page

Pages

Patient Sub Menu

Patients